Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Deloitte
US Army
Citi
US Department of Justice

Generated: May 24, 2019

DrugPatentWatch Database Preview

WYETH PHARMS INC Company Profile

« Back to Dashboard

What is the competitive landscape for WYETH PHARMS INC, and what generic and branded alternatives to WYETH PHARMS INC drugs are available?

WYETH PHARMS INC has sixteen approved drugs.



Summary for WYETH PHARMS INC
US Patents:0
Tradenames:17
Ingredients:12
NDAs:16

Drugs and US Patents for WYETH PHARMS INC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc QUINIDEX quinidine sulfate TABLET, EXTENDED RELEASE;ORAL 012796-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc EFFEXOR venlafaxine hydrochloride TABLET;ORAL 020151-002 Dec 28, 1993 DISCN Yes No ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc CORDARONE amiodarone hydrochloride INJECTABLE;INJECTION 020377-001 Aug 3, 1995 DISCN Yes No ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc LEVONORGESTREL levonorgestrel IMPLANT;IMPLANTATION 020627-001 Aug 15, 1996 DISCN No No ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc PIPRACIL piperacillin sodium INJECTABLE;INJECTION 062750-001 Oct 13, 1987 DISCN No No ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc PIPRACIL piperacillin sodium INJECTABLE;INJECTION 050545-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc PIPRACIL piperacillin sodium INJECTABLE;INJECTION 050545-006 Sep 30, 1985 DISCN Yes No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for WYETH PHARMS INC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc EFFEXOR venlafaxine hydrochloride TABLET;ORAL 020151-005 Dec 28, 1993 5,916,923 ➤ Sign Up
Wyeth Pharms Inc EFFEXOR venlafaxine hydrochloride TABLET;ORAL 020151-006 Dec 28, 1993 4,535,186*PED ➤ Sign Up
Wyeth Pharms Inc MYLOTARG gemtuzumab ozogamicin INJECTABLE;INJECTION 021174-001 May 17, 2000 5,079,233 ➤ Sign Up
Wyeth Pharms Inc LODINE etodolac CAPSULE;ORAL 018922-003 Jan 31, 1991 3,939,178 ➤ Sign Up
Wyeth Pharms Inc PREMPRO (PREMARIN;CYCRIN) estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020303-001 Dec 30, 1994 5,210,081 ➤ Sign Up
Wyeth Pharms Inc EFFEXOR venlafaxine hydrochloride TABLET;ORAL 020151-004 Dec 28, 1993 5,916,923 ➤ Sign Up
Wyeth Pharms Inc LODINE etodolac CAPSULE;ORAL 018922-002 Jan 31, 1991 3,939,178 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for WYETH PHARMS INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 25 mg, 37.5 mg, 50 mg, 75 mg and 100 mg ➤ Subscribe 2005-11-03
➤ Subscribe Tablets 0.09 mg/0.02 mg ➤ Subscribe 2007-10-05
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
QuintilesIMS
Boehringer Ingelheim
Express Scripts
Harvard Business School
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.